Tangchun Wu Selected Research

Carcinogenesis

1/2019	Multiple metals exposure and chromosome damage: Exploring the mediation effects of microRNAs and their potentials in lung carcinogenesis.
10/2015	Exposure to airborne PM2.5 suppresses microRNA expression and deregulates target oncogenes that cause neoplastic transformation in NIH3T3 cells.
6/2015	The interaction of APEX1 variant with polycyclic aromatic hydrocarbons on increasing chromosome damage and lung cancer risk among male Chinese.
7/2014	A genome-wide gene-environment interaction analysis for tobacco smoke and lung cancer susceptibility.
4/2010	Functional promoter -1271G>C variant of HSPB1 predicts lung cancer risk and survival.
9/2009	Functional FEN1 polymorphisms are associated with DNA damage levels and lung cancer risk.
9/2006	Association of polymorphisms in AhR, CYP1A1, GSTM1, and GSTT1 genes with levels of DNA damage in peripheral blood lymphocytes among coke-oven workers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tangchun Wu Research Topics

Disease

25	Coronary Disease (Coronary Heart Disease) 12/2023 - 07/2004
22	Lung Neoplasms (Lung Cancer) 01/2021 - 07/2006
19	Neoplasms (Cancer) 01/2022 - 06/2007
16	Type 2 Diabetes Mellitus (MODY) 10/2023 - 07/2015
16	Cardiovascular Diseases (Cardiovascular Disease) 07/2023 - 01/2012
14	Hypertension (High Blood Pressure) 07/2023 - 07/2004
8	Stroke (Strokes) 07/2023 - 07/2004
8	Genetic Predisposition to Disease (Genetic Predisposition) 01/2023 - 01/2019
7	Carcinogenesis 01/2019 - 09/2006
6	Acute Coronary Syndrome 07/2023 - 01/2011
6	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 06/2008
5	Ischemic Stroke 07/2023 - 09/2004
5	Overweight 10/2020 - 01/2016
4	Genetic Risk Score 04/2024 - 08/2013
4	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2016
4	Atherosclerosis 01/2021 - 01/2005
3	Hyperlipidemias (Hyperlipidemia) 07/2023 - 01/2017
3	Chronic Renal Insufficiency 12/2021 - 01/2020
3	Obesity 10/2020 - 02/2016
3	Inflammation (Inflammations) 01/2020 - 03/2015
3	Heart Failure 01/2019 - 01/2013
3	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 04/2016
3	Infections 01/2017 - 10/2014
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2012 - 01/2005
2	Pancreatic Neoplasms (Pancreatic Cancer) 05/2024 - 01/2022
2	Hyperuricemia 08/2023 - 06/2014
2	COVID-19 08/2023 - 01/2023
2	Hemorrhagic Stroke 07/2023 - 01/2019
2	Dyslipidemias (Dyslipidemia) 01/2023 - 12/2021
2	Adenocarcinoma of Lung 01/2021 - 08/2010
2	Asthma (Bronchial Asthma) 01/2019 - 02/2005
2	Breast Neoplasms (Breast Cancer) 01/2018 - 01/2011
2	Liver Neoplasms (Liver Cancer) 01/2018 - 01/2014
2	Pathologic Processes 01/2017 - 03/2004
2	Diabetes Mellitus 04/2016 - 10/2013
2	Disease Susceptibility (Diathesis) 11/2015 - 01/2015
2	Chronic Obstructive Pulmonary Disease (COPD) 05/2015 - 05/2015
2	Pneumoconiosis 12/2014 - 01/2012
2	Myocardial Ischemia (Ischemic Heart Diseases) 09/2014 - 01/2012
2	Genomic Instability 05/2014 - 09/2009
2	Myocardial Infarction 04/2014 - 10/2007
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2014 - 12/2010
2	Xeroderma Pigmentosum (Kaposi's Disease) 06/2008 - 05/2007
2	Atrial Fibrillation 01/2007 - 01/2004

Drug/Important Bio-Agent (IBA)

15	Biomarkers (Surrogate Marker)IBA 05/2024 - 07/2006
11	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 10/2013
10	MetalsIBA 12/2023 - 10/2017
9	LipidsIBA 12/2023 - 01/2011
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2003
9	MicroRNAs (MicroRNA)IBA 01/2022 - 04/2014
8	ORALIT (ORS)IBA 12/2023 - 01/2013
8	Heat-Shock Proteins (Heat-Shock Protein)IBA 09/2010 - 01/2004
7	Uric Acid (Urate)IBA 08/2023 - 08/2013
6	MetalloidsIBA 12/2023 - 01/2020
6	ZincIBA 12/2023 - 01/2019
6	BilirubinIBA 01/2019 - 01/2016
6	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 06/2015 - 09/2006
5	CholesterolIBA 12/2023 - 01/2006
5	CopperIBA 12/2023 - 01/2019
5	ArsenicIBA 12/2023 - 12/2021
5	SeleniumIBA 08/2022 - 01/2019
5	Coal (Coals)IBA 01/2021 - 08/2010
5	CokeIBA 04/2017 - 05/2014
5	AntibodiesIBA 01/2006 - 01/2004
4	AntigensIBA 08/2023 - 01/2011
4	SmokeIBA 01/2016 - 08/2010
4	Silicon Dioxide (Silica)FDA LinkGeneric 12/2014 - 01/2012
4	PlatinumIBA 01/2014 - 12/2010
4	Chaperonin 60IBA 12/2008 - 01/2004
4	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 02/2005 - 01/2003
3	Particulate MatterIBA 04/2024 - 08/2015
3	RubidiumIBA 12/2023 - 01/2019
3	StrontiumIBA 08/2023 - 01/2019
3	VanadiumIBA 08/2023 - 01/2019
3	HomocysteineIBA 01/2023 - 08/2022
3	Triglycerides (Triacylglycerol)IBA 01/2022 - 10/2014
3	MolybdenumIBA 06/2020 - 01/2019
3	IronIBA 01/2019 - 05/2014
3	Blood Glucose (Blood Sugar)IBA 01/2018 - 01/2015
3	DNA (Deoxyribonucleic Acid)IBA 07/2015 - 01/2013
3	EnzymesIBA 09/2010 - 06/2007
2	ManganeseIBA 12/2023 - 01/2019
2	Pyrethrins (Pyrethroids)FDA Link 10/2023 - 09/2022
2	BariumIBA 08/2023 - 12/2021
2	AluminumIBA 08/2023 - 12/2021
2	Complement System Proteins (Complement)IBA 03/2022 - 12/2014
2	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 12/2017
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2022 - 10/2020
2	Urea (Carbamide)FDA LinkGeneric 01/2021 - 01/2017
2	CreatinineIBA 01/2021 - 02/2020
2	NitrogenIBA 01/2021 - 01/2017
2	Indicators and Reagents (Reagents)IBA 10/2019 - 01/2005
2	Alanine Transaminase (SGPT)IBA 03/2019 - 07/2015
2	CytokinesIBA 01/2019 - 01/2017
2	TitaniumIBA 01/2019 - 01/2019
2	Fetal Proteins (Fetoprotein)IBA 01/2018 - 01/2014
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2017 - 07/2015
2	CarcinogensIBA 11/2013 - 07/2006
2	Selenium CompoundsIBA 05/2008 - 07/2007

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 01/2014 - 12/2010